Eosinophil Biology in Immune Regulation

Eosinophils are specialised granulocytes that play multifaceted roles across innate and adaptive immunity. Arising from bone marrow under the control of growth factors such as interleukin-5, they circulate at low levels in healthy individuals and migrate to tissues in response to chemokines. Their cytoplasmic granules contain an array of cationic proteins, enzymes and cytokines, which are released upon activation to modulate host defence, tissue repair and inflammatory cascades. Beyond their well-established roles in antiparasitic responses and allergic inflammation, eosinophils contribute to homeostatic processes in bone remodelling, metabolism and mucosal barrier integrity. Through direct interactions with stromal cells and modulation of T-helper cell subsets, they influence osteoclast differentiation, vascular calcification and epithelial-immune crosstalk. Dysregulation of eosinophil trafficking or degranulation underlies a spectrum of chronic conditions, from asthma and inflammatory bowel disease to cardiovascular pathology. Recent advances have uncovered signalling pathways by which eosinophil-derived mediators engage receptors on neighbouring cells to regulate gene expression and matrix remodelling. Collectively, these findings position eosinophils as central regulatory nodes in immune networks and prime targets for therapeutic intervention in diverse diseases.

Research from Nature Portfolio

A recent study has revealed a novel role for eosinophils in skeletal homeostasis. Using both genetic models of eosinophil deficiency and transgenic mice with elevated eosinophil counts, investigators demonstrated that eosinophils localise adjacent to osteoclasts in the bone marrow and inhibit excessive bone resorption. Mechanistic analysis identified eosinophil peroxidase as a key effector that impairs reactive oxygen species production and mitogen-activated protein kinase signalling in osteoclast precursors, thereby attenuating their differentiation and demineralisation activity. Human correlation studies further linked circulating eosinophil activity with bone mass in healthy subjects and patients with inflammatory arthritis. These findings establish eosinophils as critical regulators of bone mass and highlight their potential as therapeutic modulators in metabolic bone diseases.

Eosinophil Biology in Immune Regulation publication trend

The graph below shows the total number of articles in eosinophil biology in immune regulation across all publications each year (not limited to Nature Index journals).

Technical terms

Eosinophil: A type of white blood cell containing cytoplasmic granules rich in immune mediators.

Granule: A membrane-bound organelle within eosinophils that stores cationic proteins, enzymes and cytokines.

Degranulation: The process by which eosinophils release granule contents into the extracellular space upon activation.

Cytokine: A signalling protein secreted by immune cells that modulates inflammation and cell communication.

Osteoclast: A bone-resorbing cell derived from the monocyte lineage involved in skeletal remodelling.

Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF): A growth factor that promotes proliferation and activation of eosinophils and other myeloid cells.

References

1. Cationic proteins from eosinophils bind bone morphogenetic protein receptors promoting vascular calcification and atherogenesis. European Heart Journal (2023).
2. Eosinophils preserve bone homeostasis by inhibiting excessive osteoclast formation and activity via eosinophil peroxidase. Nature Communications (2024).
3. TLR7-dependent eosinophil degranulation links psoriatic skin inflammation to small intestinal inflammatory changes in mice. Experimental & Molecular Medicine (2024).
4. Granulocyte Macrophage Colony-Stimulating Factor-Activated Eosinophils Promote Interleukin-23 Driven Chronic Colitis. Immunity (2015).